Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure

International Journal of Cardiology

Volumn 170, Issue 3, 2014, Pages

  Eng, Marvin ^a   Bansal, Shweta ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute decompensated heart failure; Aldosterone antagonists; Loop diuretic resistance

Indexed keywords

FUROSEMIDE; METOLAZONE; POTASSIUM; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; AGED; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; FEMALE; FOLLOW UP; HEART VENTRICLE OVERLOAD; HUMAN; KIDNEY FAILURE; LETTER; MIDDLE AGED; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; WEIGHT REDUCTION;

ACUTE DECOMPENSATED HEART FAILURE; ALDOSTERONE ANTAGONISTS; LOOP DIURETIC RESISTANCE;

ACUTE DISEASE; AGED; DIURETICS; DRUG RESISTANCE; FEMALE; HEART FAILURE; HUMANS; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; NATRIURESIS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 84890931629     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.023     Document Type: Article

References (10)

1. W.F. Peacock, M.R. Costanzo, and T. De Marco et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry Cardiology 113 2009 12 19
2. J.T. Heywood, G.C. Fonarow, and M.R. Costanzo et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
3. M.R. Costanzo, M.E. Guglin, and M.T. Saltzberg et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 2007 675 683
4. B.A. Bart, S.R. Goldsmith, and K.L. Lee et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med 367 2012 2296 2304
5. S. Bansal, J. Lindenfeld, and R.W. Schrier Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2 2009 370 376
6. B. Pitt, F. Zannad, and W.J. Remme et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
7. D.H. Ellison Diuretic therapy and resistance in congestive heart failure Cardiology 96 2001 132 143
8. J. Hensen, W.T. Abraham, J.A. Durr, and R.W. Schrier Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention Am J Nephrol 11 1991 441 446
9. A.A. van Vliet, A.J.M. Donker, J.J.P. Nauta, and F.W.A. Verheugt Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor Am J Cardiol 1993 71
10. E. Braunwald, W.H. Plauth Jr., and A.G. Morrow A method for the detection and quantification of impaired sodium excretion: results of an oral sodium tolerance test in normal subjects and in patients with heart disease Circulation 32 1965 223 231